aprepitant capsule aprepitant aprepitant kit
1 INDICATIONS AND USAGE Aprepitant is a substance P/neurokinin 1 (NK1) receptor antagonist. Aprepitant capsules are indicated • in combination with other antiemetic agents, in patients 12 years of age and older for prevention of: o acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy (HEC) including high-dose cisplatin ( 1.1 ) o nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy (MEC) ( 1.1 ) • for prevention of postoperative nausea and vomiting (PONV) in adults ( 1.2 ) Limitations of Use : ( 1.3 ) • Aprepitant has not been studied for treatment of established nausea and vomiting. • Chronic continuous administration of aprepitant is not recommended.
torrent pharmaceuticals limited
CAPSULE PINK 125mg
Related Pills
aprepitant capsule aprepitant aprepitant kit
torrent pharmaceuticals limited
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING •
APREPItanT capsules, USP, 40 mg, are hard gelatin capsules with white body and yellow cap with "40 mg" printed in black ink on the body. NDC 13668-591-81 Carton of 1 capsule (containing 1 x 1 unit-dose blister) NDC 13668-591-82 Carton of 5 capsules (containing 5 x 1 unit-dose blisters) •
APREPItanT capsules, USP, 80 mg, are hard gelatin capsules with white body and white cap with "80 mg" printed in black ink on the body. NDC 13668-592-84 Carton of 2 capsules (containing 2 x 1 unit-dose blisters) NDC 13668-592-86 Carton of 6 capsules (containing 3 x 2 dose blisters each) •
APREPItanT capsules, USP, 125 mg, are hard gelatin capsules with white body and pink cap with "125 mg" printed in black ink on the body. NDC 13668-593-86 Carton of 6 capsules (containing 6 x 1 unit-dose blister) •
APREPItanT capsules, USP, Tri-pack-wallet type, 3-day pack (125-mg/80-mg/80-mg) 80 mg, are hard gelatin capsules with white body and white cap with "80 mg" printed in black ink on the body. 125 mg, are hard gelatin capsules with white body and pink cap with "125 mg" printed in black ink on the body. Blister pack of 2, 80 mg capsules and 1, 125 mg capsule NDC 13668-594-87 Carton of 3 capsules (3-day pack blister tri-pack containing one 125 mg capsule and two 80 mg capsules) Storage and Handling capsules Store at 20 to 25°C (68 to 77°F) [see USP Controlled Room Temperature].
More pills like CAPSULE 125mg